MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, INBX has $183,967K in assets. $205,002K in debts. $161,657K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
646.28%
Quick Ratio
646.28%
Cash Ratio
609.75%
Debt to Asset Ratio
111.43%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating right-of-use asset
    • Other non-current assets
    • Other receivables
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in-capital
    • Long-term debt, net
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
161,657 124,220 153,088 186,567
Accounts receivable-Related Party
-0 0 0
Accounts receivable-Nonrelated Party
-0 110 237
Other receivables
186 177 727 730
Prepaid expenses and other current assets
9,498 8,435 7,498 6,430
Total current assets
171,341 132,832 161,423 193,964
Property and equipment, net
3,196 3,733 4,306 4,885
Operating right-of-use asset
5,052 5,535 6,004 6,460
Other non-current assets
4,378 4,378 5,738 6,809
Total assets
183,967 146,478 177,471 212,118
Accounts payable
8,762 5,944 6,773 8,292
Accrued expenses
15,342 25,529 26,963 28,478
Current portion of operating lease liability
2,408 2,326 2,247 2,169
Total current liabilities
26,512 33,799 35,983 38,939
Long-term debt, net
174,994 100,559 99,917 99,279
Non-current portion of operating lease liability
3,496 4,127 4,741 5,341
Total liabilities
205,002 138,485 140,641 143,559
Common stock, 0.0001 par value 120,000,000 shares authorized as of march31, 2026 and december31, 2025 14,607,286 shares issued and outstanding as of march31, 2026 and 14,577,609 shares issued and outstanding as of december31, 2025
1 1 1 1
Additional paid-in-capital
258,592 254,179 250,182 246,655
Accumulated deficit
-279,628 -246,187 -213,353 -178,097
Total stockholders equity (deficit)
-21,035 7,993 36,830 68,559
Total liabilities and stockholders equity (deficit)
183,967 146,478 177,471 212,118
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$161,657K Prepaid expenses andother current assets$9,498K Other receivables$186K Total current assets$171,341K Operating right-of-useasset$5,052K Other non-currentassets$4,378K Property and equipment,net$3,196K Total assets$183,967K Accumulated deficit-$279,628K Total liabilities andstockholders equity...$183,967K Total stockholdersequity (deficit)-$21,035K Additionalpaid-in-capital$258,592K Common stock, 0.0001par value...$1K Total liabilities$205,002K Long-term debt, net$174,994K Total currentliabilities$26,512K Non-current portion ofoperating lease liability$3,496K Accrued expenses$15,342K Accounts payable$8,762K Current portion ofoperating lease liability$2,408K

Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences, Inc. (INBX)